Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · January 26, 2022

Efficacy of Subcutaneous vs Oral Methotrexate in Patients With Psoriasis Vulgaris

Clinical and Experimental Dermatology


Additional Info

Clinical and Experimental Dermatology
Comparison of the clinical efficacy of subcutaneous versus oral administration of methotrexate in patients with psoriasis vulgaris: a randomized controlled trial
Clin Exp Dermatol 2022 Jan 11;[EPub Ahead of Print], C Choonhakarn, S Chaowattanapanit, N Julanon, P Limpawattana

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading